payables 16. Debentures and debt instruments 17. Other derivatives liabilities 18. Provision 19. Other liabilities Total liabilities Shareholders’ equity 20. Share capital 20.1 Authorized share capital 20.2

business payables 16. Debentures and debt instruments 17. Other derivatives liabilities 18. Provision 19. Other liabilities Total liabilities Shareholders’ equity 20. Share capital 20.1 Authorized share

the year 2017 with net profit of 30.02 million baht or 4.88% of total revenues. The profit decreased by 11.90 million baht or 2.42 baht per share, mainly due to the continuous appreciation of the Thai

the 1st quarter was 104.8 million baht decrease 11.4 %. Net profit margin equal to 3.9% equivalent to the ratio of earning per share to 0.116 the decrease was a result of the economic slowdown and the

fee from 100 baht to 50 baht per round for debtor (one installment past-due) Notification of Debt Collection Supervisory Committee, which effective September 13, 2021 onward. However, our revenue from

of a Bank’s debtor as described above. The expenses arising from such transaction are not deductible for tax purposes. Basic earnings per share at Baht 1.83 per share. Annualized Ratios 3Q17 9M17 1Q18

of a Bank’s debtor as described above. The expenses arising from such transaction are not deductible for tax purposes. Basic earnings per share at Baht 1.83 per share. Annualized Ratios 3Q17 9M17 1Q18

selling of investment units to increase authorized share capital, to be announced within the day of the selling of investment units. Net asset values and investment unit values under paragraph one

be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain